If you made any changes in Pure these will be visible here soon.

Personal profile


Professor Ian Davis MB BS PhD FRACP FAChPM is a medical oncologist, cancer immunologist, clinician-scientist, and NHMRC Practitioner Fellow. He is Professor of Medicine, Monash University and Eastern Health, and Head of the Eastern Health Clinical School (EHCS), where he is responsible for all clinical research within Eastern Health through the Monash Eastern Clinical Research Unit (ECRU). He holds honorary appointments with the Olivia Newton-John Cancer Research Institute (formerly Ludwig Institute for Cancer Research) and Austin Health, and is an adjunct Associate Professor of the University of Melbourne, and Associate of the University of Sydney. His primary clinical interests are in urologic cancer and in melanoma, and his primary research interests are in cancer immunology and the biology of urologic cancers. He heads the Uro-oncology Laboratory at EHCS in which basic and translational research occurs in prostate cancer, and leads the Eastern Health genitourinary cancer clinical trial program. Prof Davis is the founder of the Urologic Oncology Group of the Clinical Oncology Society of Australia (COSA), member of COSA Council, and previously COSA Board director. He is founder of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Ltd (ANZUP). He is chair of the ANZUP Board and of its Scientific Advisory Committee. Prof Davis has published over 220 papers, attracted over $27M in grant funding, and been involved in over 180 clinical trials for which he was global or site Principal Investigator in over 120.

Education/Academic qualification

Cancer immunology, PhD, University of Melbourne

Medicine, MB BS (First class honours), MONASH UNIVERSITY

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2012 2021

Genomic & immunological predictors of response to intravesical therapy

Sengupta, S., Tran, B., Sluka, P., Anderson, P., Hayne, D. & Davis, I.


Project: Research

Out with Cancer: LGBTI experiences of cancer survivorship and care

Ussher, J. M., Perz, J., Hickey, M., Chambers, S. K., Dowsett, G. W., Robinson, K., Boydell, K., Davis, I., Parton, C., Anazodo, A. & McDonald, F.


Project: Research

Centre for Research Excellence in Prostate Cancer Survivorship (CRE-PCS)

Chambers, S. K., Newton, R. U., Scuffham, P., Baade, P., Galvao, D. A., Dunn, J., Smith, D., Wittert, G. A., Davis, I. & Gardiner, F.


Project: Research

Research Output 1991 2019

1 Citation (Scopus)

Assessment of Simplified Methods for Quantification of 18F-FDHT Uptake in Patients with Metastatic Castration-Resistant Prostate Cancer

Kramer, G. M., Yaqub, M., Vargas, H. A., Schuit, R. C., Windhorst, A. D., van den Eertwegh, A. J. M., van der Veldt, A. A. M., Bergman, A. M., Burnazi, E. M., Lewis, J. S., Staton, K. D., Beattie, B. J., Humm, J. L., Davis, I. D., Weickhardt, A. J., Scott, A. M., Morris, M. J., Hoekstra, O. S. & Lammertsma, A. A., 1 Sep 2019, In : Journal of Nuclear Medicine. 60, 9, p. 1221-1227 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Body size and dietary risk factors for aggressive prostate cancer: a case–control study

Pal, M., Hodge, A. M., Papa, N., MacInnis, R. J., Bassett, J. K., Bolton, D., Davis, I. D., Millar, J., English, D. R., Hopper, J. L., Severi, G., Southey, M. C., Milne, R. L. & Giles, G. G., Dec 2019, In : Cancer Causes and Control. 30, 12, p. 1301-1312 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Circulating oestrogen receptor mutations and splice variants in advanced prostate cancer

Qu, L. G., Wardan, H., Davis, I. D., Iddawela, M., Sluka, P. & Pezaro, C. J., 1 Nov 2019, In : BJU International. 124, S1, p. 50-56 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
2 Citations (Scopus)

Clinical Trials of Metastatic Castration-sensitive Prostate Cancer: Recent Progress and New Horizons

Hamid, A. A., Morris, M. J. & Davis, I. D., 1 Mar 2019, In : European Urology Focus. 5, 2, p. 165-167 3 p.

Research output: Contribution to journalArticleOtherpeer-review

Enzalutamide in Metastatic Prostate Cancer. Reply

Davis, I. D., Stockler, M. R. & Sweeney, C. J., 10 Oct 2019, In : New England Journal of Medicine. 381, 15, p. 1494-1495 2 p.

Research output: Contribution to journalLetterOtherpeer-review